secwatch.observer — SEC 8-K summary
======================================

Issuer:     MESA LABORATORIES INC /CO/ (MLAB)
CIK:        0000724004
Form:       8-K
Filed at:   2022-02-03T23:59:59+00:00
Accession:  0001437749-22-002289
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mesa Labs Q3 revenue up 60% to $54.7M; GAAP operating loss $2.5M on Agena acquisition costs
--------------------------------------------------------------------------------

- Q3 revenue $54.7M (+60% YoY); organic revenue growth 12%.
- GAAP operating loss $2.5M; net loss $0.39/diluted share.
- Non-GAAP adjusted op. income $7.1M; excl. unusual items $13.8M (+73%).
- Biopharma division organic growth 46%; Calibration Solutions revenue fell 6%.
- Acquired Agena Bioscience in Oct 2021; cash reserves fell from $264M to $52M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/724004/000143774922002289/0001437749-22-002289-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/724004/000143774922002289/mlab20220201_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-002289

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer